[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Moderna Stock Plunges After Analyst Downgrade",
    "summary": "The S&P 500 fell 0.5% on Wednesday, Jan. 29, as the Federal Reserve held interest rates steady in a move widely expected by the financial markets.",
    "url": "https://finnhub.io/api/news?id=62f0dbcb8aba14e957161fbba8ab960b8b08db3c854ae1b48fba7abd665af507",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738187710,
      "headline": "S&P 500 Gains and Losses Today: Moderna Stock Plunges After Analyst Downgrade",
      "id": 132574547,
      "image": "https://www.investopedia.com/thmb/KOxxYCdG1HY_89e6IA1vzAWelvQ=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2158994423-7b07caaf6c944faeaae1f8fa0816d29d.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 fell 0.5% on Wednesday, Jan. 29, as the Federal Reserve held interest rates steady in a move widely expected by the financial markets.",
      "url": "https://finnhub.io/api/news?id=62f0dbcb8aba14e957161fbba8ab960b8b08db3c854ae1b48fba7abd665af507"
    }
  },
  {
    "ts": null,
    "headline": "Why MRNA Stock Is Retreating",
    "summary": "mRNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 revenue guidance, based on relatively weak demand for its Covid and RSV shots. The latest guidance reduction was the second time in the […]",
    "url": "https://finnhub.io/api/news?id=79560ac2a9b4cfda4334d7761a0b8f2eadc64e7fce4dcbec0ccafa3a899fec46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738177718,
      "headline": "Why MRNA Stock Is Retreating",
      "id": 132574548,
      "image": "https://s.yimg.com/ny/api/res/1.2/ss7LBw0NkRteO60GW_xAKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3355ab936103e2e5a7e230b963727612",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "mRNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 revenue guidance, based on relatively weak demand for its Covid and RSV shots. The latest guidance reduction was the second time in the […]",
      "url": "https://finnhub.io/api/news?id=79560ac2a9b4cfda4334d7761a0b8f2eadc64e7fce4dcbec0ccafa3a899fec46"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.",
    "summary": "Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.",
    "url": "https://finnhub.io/api/news?id=3348f9ae0d6c47c05fc490f59116ed53dd7d945d3f333a9f725ba77ea6e8f515",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738162260,
      "headline": "Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.",
      "id": 132574550,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.",
      "url": "https://finnhub.io/api/news?id=3348f9ae0d6c47c05fc490f59116ed53dd7d945d3f333a9f725ba77ea6e8f515"
    }
  },
  {
    "ts": null,
    "headline": "Moderna stock drops as Goldman Sachs cuts rating",
    "summary": "Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy.",
    "url": "https://finnhub.io/api/news?id=385971fc63571a0caa937711c5de24301386fdc77c9b98cadc18e450943dfc89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738162192,
      "headline": "Moderna stock drops as Goldman Sachs cuts rating",
      "id": 132574551,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy.",
      "url": "https://finnhub.io/api/news?id=385971fc63571a0caa937711c5de24301386fdc77c9b98cadc18e450943dfc89"
    }
  },
  {
    "ts": null,
    "headline": "The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings",
    "summary": "Biotech stocks will need to brace for political \"games\" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS.",
    "url": "https://finnhub.io/api/news?id=2a94d0324e23145193ab7f1ab6708bb3eae50e5e2d2f030122e395012682c966",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738155629,
      "headline": "The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings",
      "id": 132505707,
      "image": "https://media.zenfs.com/en/ibd.com/a637dba79283d1e007dc4a7aa0c2cb33",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotech stocks will need to brace for political \"games\" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS.",
      "url": "https://finnhub.io/api/news?id=2a94d0324e23145193ab7f1ab6708bb3eae50e5e2d2f030122e395012682c966"
    }
  },
  {
    "ts": null,
    "headline": "Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.",
    "summary": "Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.",
    "url": "https://finnhub.io/api/news?id=2f7192b9d7a65831e6d6af2b4e8e256915e1d48c9e15f8e405b643f59a2dd076",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738140600,
      "headline": "Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.",
      "id": 132524597,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.",
      "url": "https://finnhub.io/api/news?id=2f7192b9d7a65831e6d6af2b4e8e256915e1d48c9e15f8e405b643f59a2dd076"
    }
  }
]